Differences in effects of omalizumab on late-phase responses to allergen challenge in the skin and nose at the time of basophil hyporesponsiveness

MeSH terms

• Allergens / immunology*
• Animals
• Anti-Allergic Agents / therapeutic use*
• Antibodies, Anti-Idiotypic / therapeutic use*
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Asthma / drug therapy
• Basophils / cytology*
• Basophils / drug effects
• Cats
• Double-Blind Method
• Histamine / immunology
• Humans
• Hypersensitivity / drug therapy*
• Nose / drug effects
• Nose / immunology
• Omalizumab
• Skin / drug effects
• Skin / immunology